Access the full text.
Sign up today, get DeepDyve free for 14 days.
Robert Griffiths, Peggy Schrammel, George Morris, Stacey Wills, D. Labiner, M. Strauss (1999)
Payer Costs of Patients Diagnosed with EpilepsyEpilepsia, 40
M. Weissman, R. Bland, G. Canino, C. Faravelli, S. Greenwald, H. Hwu, Peter Joyce, E. Karam, C. Lee, J. Lellouch, Jean-Pierre, S. Newman, M. Rubio‐Stipec, J. Wells, P. Wickramaratne, H. Wittchen, Eng-Kung Yeh (1996)
Cross-national epidemiology of major depression and bipolar disorder.JAMA, 276 4
Wyatt (1995)
An economic evaluation of manic-depressive illness - 1991Soc Psychiatry & Psychiatric Epidemiol, 30
P. Keck, S. McElroy, S. Stanton, J. Bennett (1996)
Pharmacoeconomic Aspects of the Treatment of Bipolar DisorderPsychiatric Annals, 26
A. Armond (1998)
The social and economic effects of manic depressive illness and of its treatment in lithium clinics.Occupational medicine, 48 8
M. Gitlin, J. Swendsen, T. Heller, C. Hammen (1995)
Relapse and impairment in bipolar disorder.The American journal of psychiatry, 152 11
Gregory Simon, Jürgen Unützer (1999)
Health care utilization and costs among patients treated for bipolar disorder in an insured population.Psychiatric services, 50 10
D. Regier, W. Narrow, D. Rae, R. Manderscheid, B. Locke, F. Goodwin (1993)
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.Archives of general psychiatry, 50 2
D. Regier, R. Hirschfeld, Frederick Goodwin, J. Burke, Joyce Lazar, Lewis Judd (1988)
The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis.The American journal of psychiatry, 145 11
Hosp & Community Psychiatry, 44
Myrna Weissman, P. Leaf, G. Tischler, D. Blazer, M. Karno, M. Bruce, Louis Florio (1988)
Affective disorders in five United States communitiesPsychological Medicine, 18
D. Solomon, G. Keitner, Ivan Miller, Shea Mt, M. Keller (1995)
Course of illness and maintenance treatments for patients with bipolar disorder.The Journal of clinical psychiatry, 56 1
R. Kessler, K. Mcgonagle, Shanyang Zhao, C. Nelson, M. Hughes, S. Eshleman, H. Wittchen, K. Kendler (1994)
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.Archives of general psychiatry, 51 1
Rachel Jenkins (1997)
Reducing the burden of mental illnessThe Lancet, 349
C. Murray, Alan Lopez (1997)
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyThe Lancet, 349
W. Coryell, W. Scheftner, M. Keller, J. Endicott, J. Maser, G. Klerman (1993)
The enduring psychosocial consequences of mania and depression.The American journal of psychiatry, 150 5
P. Keck, S. McElroy, S. Strakowski, S. West, J. Hawkins, TAMMY Huber, R. Newman, Michael DePRIEST (1995)
Outcome and Comorbidity in First- Compared with Multiple‐Episode ManiaThe Journal of Nervous and Mental Disease, 183
G. Winokur, W. Coryell, H. Akiskal, J. Endicott, M. Keller, T. Mueller (1994)
Manic‐depressive (bipolar) disorder: the course in light of a prospective ten‐year follow‐up of 131 patientsActa Psychiatrica Scandinavica, 89
Objective: This study examined health care resource utilization and direct health care costs among patients diagnosed with bipolar I disorder in a privately insured population. Methods: Health care claims data for 2883 patients with a primary diagnosis of bipolar disorder were compared over a 1‐year period (1997) with claims data for 2883 randomly selected, age‐ and sex‐matched, non‐bipolar patients, all covered under the same large private insurer in USA. Resource use (i.e. original and refill pharmaceutical dispensing, medical and procedural services received, inpatient hospitalization, outpatient services, physician visits and emergency room treatment) and their costs are described overall, as well as by bipolar disorder diagnosis (based on ICD‐9 codes) and type of care (i.e. mental health versus non‐mental health). Results: Bipolar patients utilized nearly three to four times the health care resources and incurred over four times greater costs per patient compared with the non‐bipolar group during the 1‐year period ($7663 versus $1962). Inpatient care (hospitalizations) accounted for the greatest disparity between groups, as it was the single‐most costly resource in the bipolar group ($2779 versus $398). Patients with bipolar depression (among the single bipolar diagnostic categories of mixed, manic or depressed) incurred the highest health care costs. While mental health care cost was a significant component of total cost in the bipolar group, it accounted for only 22% of the total per‐patient cost; in comparison, it accounted for only 6% of the total per‐patient cost in the non‐bipolar group. Conclusion: Treatment of bipolar disorder, particularly inpatient care, is costly to patients and health insurers. Further study is needed to find ways to reduce the overall cost of managing these patients without jeopardizing patient care.
Bipolar Disorders – Wiley
Published: Dec 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.